Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Role of Stigma in Opioid Use Disorder


 

Role of Stigma in Opioid Use Disorder

 
This Opioid Training Initiative course was developed for healthcare practitioners who work with individuals with opioid use disorder and other substance use disorders.  The goal of this course is to help the practitioner define stigma and its historical origins Identify different types of stigma and  discuss how stigma decreases access to care for people with substance use disorders.  Stigma and the personal experience of patients who are subject to stigma language from healthcare professionals is a major obstacle in their treatment.  Understanding the impact of stigma including body language, interpersonal communication and environmental factors pay a major role in treatment results.
 
The information in this course has been specifically tailored to meet the needs of clinicians practicing in Texas with a focus on regional trends, laws and regulations.

Faculty

Richard Bottner, DHA, PA-C
Assistant Professor, Department of Internal Medicine
The University of Texas at Austin Dell Medical School

Richard Bottner, DHA, PA-C is an Assistant Professor in the Department of Internal Medicine at Dell Medical School at The University of Texas at Austin. Bottner is also a physician assistant in the Division of Hospital medicine at Dell Seton Medical Center. Bottner is the Director of the Buprenorphine Team (B-Team), a full-service consultation team that provides patients who are hospitalized and have opioid use disorder access to treatment and linkage to appropriate outpatient care. The program also works to reduce stigma of patients with substance use disorders. Bottner is also the Director of Support Hospital Opioid Use Treatment (SHOUT) Texas, a TTOR-funded program seeking to increase access to opioid use disorder treatment in hospitals across the state.  

 

DISCLOSURE: Richard Bottner has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.


Learning Objectives

  • Define stigma and its historical origins
  • Identify different types of stigma
  • Discuss how stigma decreases access to care for people with substance use disorders

Continuing Education Information

ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.1 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete online evaluation.  Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system.

 

The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Long School of Medicine designates this material for a maximum of 1.0 AMA PRA Category 1 Credit™  .    


Accreditation Statement: University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Requirements for Successful Completion: To receive contact hours for this continuing education activity, the participant must sign in, attend the entire activity, pass the post-test with at least 70% correct answers, and complete and submit the evaluation form. Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 1 contact hour. Learning outcome: Registered nurses will report desire to change practice related to knowledge gain regarding stigma and its historical origins, focusing on how stigma decreases access to care for people with substance use disorders and plays a major role in treatment results. Conflicts of Interest: All activity planning committee members and presenters/authors/content reviewers have had their Conflict of Interest assessed, identified and resolved by the nurse planner. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center through the joint providership of the University of Texas at Austin School of Nursing, The University of Texas at Austin School of Pharmacy, The University of Texas at Austin Hick School of Social Work, and the UT Health San Antonio Joe R. and Teresa Lozano Long School of Medicine Continuing Medical Education. University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity expires June 18, 2023


The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work provides continuing education in accordance with the criteria and standards of the Texas Board of Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists and Licensed Psychologist under Texas Administrative Code, Title 22, Part 34. § 781.509. Complaints about this program may be made to TSBSWE, 333 Guadalupe St., Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205 • bhec.texas.gov/texas-state-board-of-social-worker-examiners/


This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians
  • Physicians
  • Psychiatrists
  • Physician Assistant
  • Social Workers
  • Counselors
  • Advance Practice Nurses (CME)
  • Nurse Practitoners (CME)

 

 

 

Role of Stigma in Opioid Use Disorder

 
Richard Bottner, DHA, PA-C
Assistant Professor, Internal Medicine
The University of Texas at Austin Dell Medical School 
 

LEARNING OBJECTIVES

  • Define stigma and its historical origins
  • Identify different types of stigma
  • Discuss how stigma decreases access to care for people with substance use disorders
 
This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Activity Number

0067-0000-21-122-H08-P/T

Release Date: Jun 18, 2021
Credit Expiration Date: Jun 17, 2024

CE Hours

1.00